Preparation and characterization of chitosan/sodium alginate (CSA) microcapsule containing Cortex Moutan

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 434, Issue , 2013, Pages 95-101

  Hui, Patrick Chi Leung ^a   Wang, Wen Yi ^a   Kan, Chi Wai ^a   Ng, Frency Sau Fun ^a   Zhou, Chang E ^a   Wat, Elaine ^b   Zhang, Vanilla Xin ^b   Chan, Chung Lap ^b   Lau, Clara Bik San ^b   Leung, Ping Chung ^b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atopic dermatitis; Cortex Moutan; Cytotoxicity test; Microencapsulation

Indexed keywords

CHEMICAL ANALYSIS; CONTROLLED DRUG DELIVERY; CROSSLINKING; CYTOTOXICITY; DERMATITIS; EMULSIFICATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MICROENCAPSULATION; MICROSTRUCTURE; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; SCANNING ELECTRON MICROSCOPY; TARGETED DRUG DELIVERY;

ATOPIC DERMATITIS; CHEMICAL CROSS-LINKING; CLINICAL TREATMENTS; CORTEX MOUTAN; CYTOTOXICITY TEST; ENCAPSULATION EFFICIENCY; PREPARATION CONDITIONS; RELEASE PERFORMANCE;

ENCAPSULATION;

ALGINIC ACID; CHITOSAN; CHITOSAN SODIUM ALGINATE; PAEONIA SUFFRUTICOSA EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CROSS LINKING; CYTOTOXICITY; DRUG RELEASE; EMULSION; ENCAPSULATION; HUMAN; HUMAN TISSUE; INFRARED SPECTROSCOPY; LASER DIFFRACTION; MICROCAPSULE; PAEONIA SUFFRUTICOSA; PARTICLE SIZE; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SKIN TOXICITY;

EID: 84878937369     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2013.05.043     Document Type: Article

References (36)

1. Jiang S.S., Nakano Y., Yatsuzuka R., Ono R., Kamei C. Inhibitory effects of Moutan Cortex on immediate allergic reactions. Biol. Pharm. Bull. 2007, 30(9):1707-1710.
2. Yang J., Kim J.S., Sa Y.J., Kim M.O., Jeong H.J., Yu C.Y., Kim M.J., Antioxidant antibacterial and α-glucosidase inhibitory activities of different extracts of Cortex Moutan. Afr. J. Biotechnol. 2011, 10(46):9438-9444.
3. Lau C.H., Chan C.M., Chan Y.W., Lau K.M., Lam T.W., Law W.T., Che C.T., Leung P.C., Fung K.P., Ho Y.Y., Lau C.B.S. Pharmacological investigations of the anti-diabetic effect of Cortex Moutan and its active component paeonol. Phytomedicine. 2007, 14:778-784.
4. Yu K., Wang Y.W., Cheng Y.Y. Determination of the active components in Chinese Herb Cortex Moutan by MEKC and LC. Chromatographia. 2006, 63:359-364.
5. Li X.Y., Tu W.Q., Zhang L.J. Determination of paeoniflorin and paeonol in Cortex Moutan by RP-HPLC. Tradit. Chin. Drug Res. Clin. Pharmacol. 2011, 22(5):563-565.
6. Wang B., Yan G. Structure and antitumor (LOMO) activity of Cortex Moutan heteroglycan and curumin. Carbohydr. Polym. 2011, 86:520-525.
7. Chan B.C.L., Hon K.L.E., Leung P.C., Sam S.W., Fung K.P., Lau H.Y. Traditional Chinese medicine for atopic eczema: pentaherbs formula suppresses inflammatory mediators release from mast cells. J. Ethnopharmacol. 2008, 120:85-91.
8. Hon K.L.E., Lee V.W.Y., Leung T.F., Lee K.K.C., Chan A.K.W., Fok T.F., Leung P.C. Corticosteroids are not present in a traditional Chinese medicine formulation for atopic dermatitis in children. Ann. Acad. Med. Singapore 2006, 35:759-763.
9. Hon K.L.E., Leung T., Ng P.C., Lam M.C.A., Kam W.Y.C., Wong K.Y., Lee K.C.K., Sung Y.T., Cheng K.F., Fok T.F., Fung K.P., Leung P.C. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br. J. Dermatol. 2007, 157:357-363.
10. Hon K.L., Chan B.C.L., Leung P.C. Chinese herbal medicine research in eczema treatment. Chin. Med. 2011, 6:17.
11. Möhrenschlager M., Darsow U., Schnopp C., Ring J. Atopic eczema: what's new?. J. Eur. Acad. Dermatol. Venereol. 2006, 20:503-513.
12. Leung A.K., Hon K.L., Robson W.L. Atopic dermatitis. Adv. Pediatr. 2007, 54:241-273.
13. Dabade T.S., Davis D.M., Wetter D.A., Hand J.L., McEvoy M.T., Pittelkow M.R., el-Azhary R.A., Davis M.D. Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: experience with 218 patients over 30 years at Mayo Clinic. J. Am. Acad. Dermatol. 2012, 67:100-106.
14. Leung D.Y. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol. 1995, 96:302-318.
15. Foley P., Zuo Y., Plunkett A., Marks R. The frequency of common skin conditions in preschool-age children in Australia: atopic dermatitis. Arch. Dermatol. 2001, 137:293-300.
16. Leung R., Wong G., Lau J., Ho A., Chan J.K.W., Choy D. Prevalence of asthma and allergy in Hong Kong schoolchildren: an ISAAC study. Eur. Respir. J. 1997, 10:354-360.
17. Shelley D.C., Amy T. Impatient management of atopic dermatitis. Dermatol. Ther. 2011, 24:249-255.
18. Oranje A.P., Verbeek R., Verzaal P., Haspels I., Prens E., Nagelkerken L. Wet-wrap treatment using dilutions of tacrolimus ointment and fluticasone propionate cream in human APOC1 (+/+) mice with atopic dermatitis. Br. J. Dermatol. 2008, 160(1):54-61.
19. Hon K.L., Wong K.Y., Cheung L.K., Ha G., Lam M.C., Leung T.F., Chow C.M., Tang Y.M., Luk N.M., Leung A.K. Efficacy and problems associated with using a wet-wrap garment for children with severe atopic dermatitis. J. Dermatol. Treat. 2007, 18(5):301-305.
20. Lee J.H., Lee S.J., Kim D.S., Bang D. The effect of wet-warp dressing on epidermal barrier in patients with atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 2007, 21:1360-1368.
21. Ong P.Y., Ferdman R.M., Dunaway T., Church J.A., Inderlied C.B. Down-regulation of atopic dermatitis-associated serum chemokines by wet-wrap treatment: a pilot study. Ann. Allergy Asthma Immunol. 2008, 100:286-287.
22. Zhao J., Cui Y., Wang A.H., Fei J.B., Yang Y., Li J.B. Side effect reduction of encapsulated hydrocortisone crystals by insulin/alginate shells. Langmuir 2011, 27(4):1265-1271.
23. Huang L.L., Sui W.P., Wang Y.X., Jiao Q. Preparation of chitosan/chondroitin sulfate complex microcapsules application in controlled release of 5-fluorouracil. Carbohydr. Polym. 2010, 80:168-173.
24. Wang A.H., Tao C., Cui Y., Duan L., Yang Y., Li J.B. Assembly of environmental sensitive microcapsules of PNIPAAm and alginate acid and their application in drug release. J. Colloid Interface Sci. 2009, 332:271-279.
25. Yuen C.W.M., Yip J., Liu L.W., Cheuk K., Kan C.W., Cheung H.C., Cheng S.Y. Chitosan microcapsules loaded with either miconazole nitrate or clotrimazole prepared via emulsion technique. Carbohydr. Polym. 2012, 89:795-801.
26. Liu X.D., Yu W.Y., Zhang Y., Xue W.M., Yu W.T., Xiong Y., Ma X.J., Chen Y., Yuan Q. Characterization of structure and diffusion behaviour of Ca-alginate beads prepared with external or internal calcium sources. J. Microencapsul. 2002, 19(6):775-782.
27. Taqieddin E., Amiji M. Enzyme immobilization in novel alginate-chitosan core-shell microcapsules. Biomaterials 2004, 25:1937-1945.
28. Yang Y., He Q., Duan L., Cui Y., Li J.B. Assembled alginate/chitosan nanotubes for biological application. Biomaterials 2007, 28:3083-3090.
29. Hsieh W.C., Chang C.P., Gao Y.L. Controlled release properties of chitosan encapsulated volatile citronella oil microcapsules by thermal treatments. Colloids and Surfaces B: Biointerfaces 2006, 53:209-214.
30. Mi F.L., Sung H.W., Shyu S.S. Drug release from chitosan-alginate complex beads reinforced by a naturally occurring cross-linking agent. Carbohydr. Polym. 2002, 48:61-72.
31. Jia Y., Fei J.B., Cui Y., Yang Y., Gao L., Li J.B. pH-responsive polysaccharide microcapsules through covalent bonding assembly. Chem. Commun. 2011, 47:1175-1177.
32. Liu W.B., Song Z.Q., Yu G. Preparation of microcapsule used for paper using sodium alginate and chitosan as wall. China Pulp Paper 2005, 24(10):17-19.
33. Wu M., Gu Z. Screening of bioactive compounds from Moutan Cortex and their anti-inflammatory activities in rat synoviocytes. Evid. Based Complement. and Altern. Med. 2007, 6(1):57-63.
34. Olav G., Olav S., Gudmund S.B. Microcapsules of alginate-chitosan - I A quantitative study of the interaction between alginate and chitosan. Biomaterials 1998, 19:1815-1825.
35. Huguet M.L., Dellacherie E. Calcium-alginate beads coated with chitosan: effect of the structure of encapsulated materials on their release. Process Biochem. 1996, 31:745-751.
36. Hisashi M., Toshio O., Atsuhiro K., Masayuki Y. Bioactive constituents of Chinese natural medicines. VI. Moutan Cortex (2): structures and radical scavenging effects of suffruticosides A,B,C,D, and E and galloyl-oxypaeoniflorin. Chem. Pharm. Bull. 2001, 49(1):69-72.